![CureVac's COVID-19 vaccine attracts rising interest](https://www.thepeninsulaqatar.com/uploads/2021/04/15/post_main_cover/cc5321b23d2c4727fd49f06a9d2c6443367783c7.jpeg)
CureVac's COVID-19 vaccine attracts rising interest
The Peninsula
FRANKFURT: German biotech firm CureVac said it has seen the number of requests for its experimental COVID-19 vaccine increase over the past few days, as concerns over rare side effects have hit some other coronavirus shots.
A CureVac spokesman said on Thursday that requests have been coming in from various quarters, including governments and international organisations but he declined to elaborate. The group is to hold an analyst call on fourth-quarter results at 1400 GMT. The European Union in November secured up to 405 million doses of CureVac's two-shot vaccine, which has yet to win regulatory approval, the company's only large supply contract so far.More Related News